LeMaitre Vascular (LMAT) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Warby Parker (WRBY) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 1.4% versus a loss of 9.5%. Over five years, LMAT leads with a +48.6% price change compared with -54.4% for WRBY. Warby Parker is the larger company by market cap ($3.08 billion vs $1.82 billion), about 1.7 times the size, while LeMaitre Vascular is growing revenue faster (+13.5% vs +13.0%).
On valuation, LeMaitre Vascular trades at a lower forward P/E (25.1x vs 40.6x for Warby Parker). LeMaitre Vascular pays a dividend yielding 1.13%, while Warby Parker does not currently pay one. LeMaitre Vascular converts more of its revenue into profit, with a net margin of 23.1% versus 0.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMAT | WRBY |
|---|---|---|
| Share price | $79.64 | $24.95 |
| Market cap | $1.82B | $3.08B |
| 1-day change | +0.42% | -1.42% |
| YTD return | -1.80% | +14.50% |
| 1-year return | -9.54% | +1.42% |
| 5-year return | +48.64% | -54.43% |
| P/E ratio (TTM) | 27.94 | 415.83 |
| Forward P/E | 25.05 | 40.58 |
| EPS (TTM) | $2.85 | $0.06 |
| Dividend yield | 1.13% | 0.00% |
| Annual dividend | $0.90 | $0.00 |
| Revenue (latest FY) | $249.60M | $871.90M |
| Revenue growth (YoY) | +13.53% | +13.04% |
| Net income (latest FY) | $57.73M | $1.64M |
| Gross margin | 71.53% | 53.97% |
| Operating margin | 27.21% | -0.61% |
| Net margin | 23.13% | 0.19% |
| 52-week high | $118.01 | $31.00 |
| 52-week low | $78.22 | $14.96 |
| Distance from 52-week high | -32.51% | -19.52% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +34.35% | +22.08% |
| Average volume | 330.14K | 2.85M |
| Shares outstanding | 22.87M | 108.24M |
| Employees | 646 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WRBY has outperformed LMAT by 11.0 percentage points over the past year.
- Warby Parker trades at a higher earnings multiple (415.8x vs 27.9x trailing P/E).
- LeMaitre Vascular offers a meaningfully higher dividend yield (1.13% vs 0.00%).
- LeMaitre Vascular is more profitable, keeping 23.1 cents of every revenue dollar as net income versus 0.2 cents for Warby Parker.
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 646 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
LMAT vs WRBY FAQ
Which is bigger, LeMaitre Vascular or Warby Parker?
Warby Parker (WRBY) is larger, with a market capitalization of $3.08B compared with $1.82B for LeMaitre Vascular (LMAT).
Which stock has performed better over the past year, LMAT or WRBY?
WRBY returned +1.42% over the past 12 months, compared with -9.54% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, LMAT or WRBY?
LMAT has the lower trailing P/E at 27.9, versus 415.8 for WRBY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, LeMaitre Vascular or Warby Parker?
LeMaitre Vascular pays a dividend yielding 1.13%, while Warby Parker does not currently pay a regular dividend.
Are LeMaitre Vascular and Warby Parker in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for LeMaitre Vascular and Ophthalmic Goods for Warby Parker.